“…These gluconeogenic genes are mainly controlled by hepatocyte nuclear factor-4α (HNF4α), cAMP-response element-binding protein (CREB) and forkhead box O1 (FoxO1) transcription factors, PGC1α coactivator, and by GR; PPARα, LXRs, or SREBP-1c are dominant in regulation of lipid metabolism genes ( Miao et al, 2006 ; Oh et al, 2013 ; Gao et al, 2015 ). hCAR activation has previously been reported to suppress the expression of gluconeogenic enzymes G6Pase and PEPCK1 in primary human hepatocytes pre-treated with FSK ( Gao et al, 2015 ) and in mice under nutritional stress (high-fat diet, in leptin-deficient obese mice, under fasting conditions) ( Miao et al, 2006 ; Dong et al, 2009 ; Gao et al, 2009 ; Yarushkin et al, 2013 ; Yu et al, 2016 ). The regulation of the fatty acids and steroids synthetic enzymes HMGCS2 and FASN after treatment with the mCAR agonist TCPOBOP in mice after high- fat or 1% cholesterol diet has been confirmed several times ( Gao et al, 2009 ; Rezen et al, 2009 ).…”